We are live on ! Find out more
GHCM

Glen Harbor Capital Management Portfolio holdings

AUM $4.82B
1-Year Est. Return 4.69%
This Fund
S&P 500
This Quarter Est. Return
+14.25%
1 Year Est. Return
+4.69%
3 Year Est. Return
+49.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.65B
AUM Growth
+$515M
Cap. Flow
-$30.2M
Cap. Flow %
-0.65%
Top 10 Hldgs %
21.23%
Holding
1,340
New
59
Increased
498
Reduced
256
Closed
38

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.6M
2
APD icon
Air Products & Chemicals
APD
+$9.47M
3
COF icon
Capital One
COF
+$9.19M
4
PAYX icon
Paychex
PAYX
+$9.12M
5
FTNT icon
Fortinet
FTNT
+$8.23M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$30.5M
2
BA icon
Boeing
BA
+$14.8M
3
IFF icon
International Flavors & Fragrances
IFF
+$13.4M
4
HUM icon
Humana
HUM
+$12.5M
5
CI icon
Cigna
CI
+$11.6M

Sector Composition

Rank Sector Weight
1 Technology 18.32%
2 Financials 15.42%
3 Healthcare 13.08%
4 Consumer Discretionary 11.35%
5 Industrials 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RETA
1276
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$20K ﹤0.01%
238
-68
-22% -$5.64K
TRQ
1277
DELISTED
Turquoise Hill Resources Ltd
TRQ
$20K ﹤0.01%
1,234
– –
NUAN
1278
DELISTED
Nuance Communications, Inc.
NUAN
$19K ﹤0.01%
1,321
+50
+4% +$693
DNLI icon
1279
Denali Therapeutics
DNLI
$3.21B
$18K ﹤0.01%
756
– –
ESTC icon
1280
Elastic
ESTC
$8.92B
$18K ﹤0.01%
+224
New +$18.7K
TBHC
1281
DELISTED
The Brand House Collective
TBHC
$18K ﹤0.01%
2,492
– –
RNG icon
1282
RingCentral
RNG
$6.05B
$17K ﹤0.01%
160
+16
+11% +$1.57K
TWST icon
1283
Twist Bioscience
TWST
$9.72B
$17K ﹤0.01%
714
-544
-43% -$12.3K
FATE icon
1284
Fate Therapeutics
FATE
$285M
$16K ﹤0.01%
896
– –
ALTR
1285
DELISTED
Altair Engineering Inc
ALTR
$16K ﹤0.01%
440
+22
+5% +$740
SNDX icon
1286
Syndax Pharmaceuticals
SNDX
$1.61B
$15K ﹤0.01%
2,816
-550
-16% -$3.14K
ARNA
1287
DELISTED
Arena Pharmaceuticals Inc
ARNA
$15K ﹤0.01%
336
– –
SLP icon
1288
Simulations Plus
SLP
$372M
$14K ﹤0.01%
+682
New +$13.7K
UPLD icon
1289
Upland Software
UPLD
$11.8M
$14K ﹤0.01%
32
+3
+10% +$1.02K
DBX icon
1290
Dropbox
DBX
$8.24B
$11K ﹤0.01%
528
+16
+3% +$372
CSOD
1291
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$11K ﹤0.01%
208
+16
+8% +$885
ALEC icon
1292
Alector
ALEC
$230M
$10K ﹤0.01%
+560
New +$10.6K
REPL icon
1293
Replimune Group
REPL
$1.24B
$10K ﹤0.01%
656
– –
ASMB icon
1294
Assembly Biosciences
ASMB
$532M
$9K ﹤0.01%
40
-37
-48% -$9.37K
MDGL icon
1295
Madrigal Pharmaceuticals
MDGL
$12B
$8K ﹤0.01%
68
– –
VCIT icon
1296
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$68.9B
$8K ﹤0.01%
88
– –
IOVA icon
1297
Iovance Biotherapeutics
IOVA
$4.38B
$7K ﹤0.01%
752
-80
-10% -$777
CRNX
1298
DELISTED
Crinetics Pharmaceuticals
CRNX
$5K ﹤0.01%
+220
New +$5.41K
CHMA
1299
DELISTED
Chiasma, Inc. Common Stock
CHMA
$4K ﹤0.01%
+736
New +$3.24K
ALNA
1300
DELISTED
Allena Pharmaceuticals
ALNA
$3K ﹤0.01%
464
-16
-3% -$116
50 51
52
53 54

Similar funds

FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
EP
Elkfork Partners Portland, Oregon $4.11B AUM 5.26% 1-Year Est. Return
MIH
Madison Investment Holdings Madison, Wisconsin $6.16B AUM 11.67% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Glen Harbor Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Glen Harbor Capital Management held 1,340 positions worth $4.65B, up 12% from $4.14B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Glen Harbor Capital Management's Q1 2019 filing shows 59 new, 498 increased, 256 reduced and 38 closed positions. Its largest new stake was Celanese: 59,874 shares worth $5.9M. The largest sale was Celgene Corp, an estimated $30.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glen Harbor Capital Management's largest Q1 2019 buy was Celanese: 59,874 shares worth $5.9M.
  • Glen Harbor Capital Management added most to Microsoft in Q1 2019, an estimated $12.6M increase.
  • Glen Harbor Capital Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $30.5M.
  • Glen Harbor Capital Management fully exited VICI Properties in Q1 2019, selling an estimated $1.75M.
  • Glen Harbor Capital Management's ten largest holdings make up 21% of its $4.65B portfolio in Q1 2019.
  • Glen Harbor Capital Management opened 59 new positions and closed 38 in Q1 2019.
  • Glen Harbor Capital Management's portfolio value rose 12% quarter-over-quarter to $4.65B.

Based on Glen Harbor Capital Management's 13F filing for Q1 2019, filed 13 May 2019.